Literature DB >> 23611887

The impact of congenital and childhood myotonic dystrophy on quality of life: a qualitative study of associated symptoms.

Nicholas E Johnson1, Elizabeth Luebbe2, Eileen Eastwood2, Nancy Chin3, Richard T Moxley2, Chad R Heatwole2.   

Abstract

This study systematically evaluated the symptoms associated with congenital and childhood myotonic dystrophy, and how these symptoms affect health related quality of life. We conducted interviews with patients affected by congenital or childhood myotonic dystrophy and their affected parent to identify which symptoms have the greatest effect on their lives. Each interview was recorded, coded, and analyzed using a qualitative framework technique. In 34 interviews with 13 parents and 21 patients, we identified 189 symptoms, representing 22 themes in physical, emotional, social, and disease-specific quality of life. Communication difficulties, cognitive impairment, and social role limitations were the most frequently identified themes. These interviews identified multiple themes and symptoms, some previously under-recognized, which play a key role in the disease burden associated with congenital and childhood myotonic dystrophy.
© The Author(s) 2013.

Entities:  

Keywords:  congenital myotonic dystrophy; disease burden; neuromuscular disorders; quality of life; symptoms

Mesh:

Year:  2013        PMID: 23611887     DOI: 10.1177/0883073813484804

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  12 in total

1.  Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.

Authors:  Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Magalie Emile-Backer; Katherine G Meilleur
Journal:  Patient       Date:  2020-08       Impact factor: 3.883

2.  Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy.

Authors:  Nicholas E Johnson; Anne-Berit Ekstrom; Craig Campbell; Man Hung; Heather R Adams; Wei Chen; Elizabeth Luebbe; James Hilbert; Richard T Moxley; Chad R Heatwole
Journal:  Dev Med Child Neurol       Date:  2015-10-28       Impact factor: 5.449

3.  Physical function and mobility in children with congenital myotonic dystrophy.

Authors:  Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

4.  A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy.

Authors:  Kylie M Cornwall; Russell J Butterfield; Antonio Hernandez; Chad Heatwole; Nicholas E Johnson
Journal:  J Neuromuscul Dis       Date:  2018

5.  Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Authors:  Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat
Journal:  Gene Ther       Date:  2022-01-25       Impact factor: 5.250

Review 6.  Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Authors:  Ian S Mutchnick; Meena A Thatikunta; William C Gump; Dan L Stewart; Thomas M Moriarty
Journal:  Childs Nerv Syst       Date:  2016-01-08       Impact factor: 1.475

7.  Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.

Authors:  Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; Magalie Emile-Backer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Paul G Wakim; Katherine G Meilleur
Journal:  Qual Life Res       Date:  2020-02-10       Impact factor: 4.147

8.  Patient-identified impact of symptoms in spinal and bulbar muscular atrophy.

Authors:  Robert D Guber; Angela D Kokkinis; Alice B Schindler; Roxanna M Bendixen; Chad R Heatwole; Kenneth H Fischbeck; Christopher Grunseich
Journal:  Muscle Nerve       Date:  2017-09-25       Impact factor: 3.217

Review 9.  Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy.

Authors:  Sigrid Baldanzi; Giulia Ricci; Costanza Simoncini; Mirna Cosci O Di Coscio; Gabriele Siciliano
Journal:  Acta Myol       Date:  2016-12

Review 10.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.